Cloning of the promoters for the β-cell ATP-sensitive K-channel subunits Kir6.2 and SUR1

Diabetes

Volumn 47, Issue 8, 1998, Pages 1274-1280

  Ashfield, Rebecca ^a   Ashcroft, Stephen J H ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG RECEPTOR; LUCIFERASE; POTASSIUM CHANNEL; SULFONYLUREA;

ANIMAL CELL; ARTICLE; DNA FLANKING REGION; FIBROBLAST CULTURE; GENE LIBRARY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INSULIN RELEASE; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; REPORTER GENE; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; TATA BOX;

ATP-BINDING CASSETTE TRANSPORTERS; BASE SEQUENCE; CHROMOSOME MAPPING; CLONING, MOLECULAR; GENE DELETION; HUMANS; ISLETS OF LANGERHANS; MOLECULAR SEQUENCE DATA; POTASSIUM CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; PROMOTER REGIONS (GENETICS); RECEPTORS, DRUG; TRANSCRIPTION, GENETIC;

EID: 0031848442     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.8.1274     Document Type: Article

References (35)

1. Ashcroft SJH, Ashcroft FM: Properties and functions of ATP-sensitive K-channels. Cell Signal 2:197-214, 1990
2. Ashcroft SJH, Ashcroft FM: The sulfonylurea receptor. Biochim Biophys Acta Mol Cell Res 1175:45-59,1992
3. Thomas PM, Cote GJ, Wohllk N, Haddad B, Matthew PM, Rabl W, Aguilar-Bryan L, Gagel RF, Bryan J: Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science 268:426-429, 1995
4. Aguiar-Bryan L, Nichols CG, Wechsler SW, Clement JP, Boyd AE III, González G, Herrera-Sosa H, Nguy K, Bryan J, Nelson DA: Cloning of the β-cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. Science 268:42:3-426, 1995
5. Inagaki N, Gonoi T, Clement JP, Namba N, Inazawa J, Gonzalez G, Aguilar-Bryan L, Seino S, Bryan J: Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor. Science 270:1166-1170, 1995
6. Sakura H, Ämmälä C, Smith PA, Gribble FM, Ashcroft FM: Cloning and functional expression of the cDNA encoding a novel ATP-sensitive potassium channel subunit expressed in pancreatic β-cells, brain, heart, and skeletal muscle. FEBS Lett 377:338-344, 1995
7. + channels. Neuron 16:1011-1017, 1996
8. Clement JP, Kunjilwar K, Gonzalez G, Schwanstecher M, Fanten U, Aguilar-Bryan L, Bryan J: Association and stoichiometry of KATP channel subunits. Neuron 18:827-838, 1997
9. + channel. FEBS Lett 409:232-236, 1997
10. + channels in the absence of the sulphonylurea receptor. Nature 387:179-183, 1997
11. + channel Kir6.1 expressed in human embryonic kidney cells. J Physiol (Lond) 494:709-714, 1996
12. Clark AR, Docherty K: Cell-specific gene expression in the islets of Langerhans: E boxes and TAAT boxes. Biochcm Soc Trans 21:154-159, 1993
13. Madsen OD, Jensen PB, Larsson LI, Serup P: Transcription factors con- tributing to the pancreatic β-cell phenotype. Horm Metab Res 29:265-270, 1997
14. Kadonaga JT, Jones KA, Tuan R: Promoter-specific activation of RNA polymerase II transcription by Sp1. TIBS 11:20-23, 1986
15. Kennedy GC, Rutter WJ: Pur-1, a zinc-finger protein that binds to purine-rich sequences transactivates an insulin promoter in heterologous cells. Proc Natl Acad Sci U S A 89:11498-11502, 1992
16. Imagawa M, Chiu R, Karin M: Transcription factor AP-2 mediates induction by two different signal-transduction pathways: protein kinase C and cAMR Cell 51:251-260, 1987
17. Waeber G, Steinmann M, Nicod P, Bonny C: The β-cell-specific control of the insulin and GLUT2 genes is mediated, in part, by the islet-brain 1 (IB1) transactivator (Abstract). Exp Clin Eudocrinol Diabetes 105:A23, 1997
18. Ohagan RC, Tozer RG, Symons M, McCormick F, Hassell JA: The activity of the Ets transcription factor PEA3 is regulated by two distinct MAPK cascades. Oncogene 13:1323-1333, 1996
19. deLaunoit Y, Baert JL, Chotteau A, Monte D, Defossez PA, Courte L, Pelczar H, Leenders F: Structure-function relationships of the PEA3 group of Ets-related transcription factors. Biochem Mol Med 61:127-135, 1997
20. 65 promoter expression kinetics of GAD in the pancreas (Abstract). Exp Clin Endocrinol Diabetes 105:A31, 1997
21. Sander M, Neubuser A, Kalamaras J, Ee HC, Martin GR, German MS: Genetic analysis reveals that PAX6 is required for normal transcription of pancreatic hormone genes and islet development. Genes Dev 11:1662-1673, 1997
22. Vaisse C, Kim J, Espinosa R III, Le Beau MM, Stoffel M: Pancreatic islet expression studies and polymorphic DNA markers in the genes encoding hepatocyte nuclear factor-3α, -3β, -3γ, -4γ, and -6. Diabetes 46:1364-1367, 1997
23. + channel. J Biol Chem 271:24321-24324, 1996
24. Simon M, Conley EC, Shelton PA, Gutman GA, Chandy KG: Transcription of the T-cell potassium channel Kv1.3 is regulated by a GC-rich TATA-less promoter. Cell Physiol Biochem. 7:243-250, 1997
25. Wymore RS, Negulescu D, Kinoshita K, Kalman K, Aiyar J, Gutman GA, Chandy KG: Characterization of the transcription unit of mouse Kv1.4, a volt- age-gated potassium channel gene. J Biol Chem 271:15629-15634, 1996
26. Yoshinuira K, Nakamura H, Trapnell BC, Dalemans W, Pavirani A, Lecocq J-P, Crystal RG: The cystic fibrosis gene has a "housekeeping"-type promoter and is expressed at low levels in cells of epithelial origin. J Biol Chem 266:9140-9144, 1991
27. Blackwell TK, Weintraub H: Differences and similarities in DNA binding preferences of MyoD and E2A protein complexes revealed by binding site selection. Science 250:1104-1110, 1990
28. Pittman N, Shue G, LeLeiko NS, Walsh MJ: Transcription of cystic fibrosis transmembrane conductance regulator requires a CCAAT-like element for both basal and cAMP-mediated regulation. J Biol Chem 270:2884-28857, 1995
29. Yamagata K, Oda N, Kaisaki PJ, Menzel S, Furuta H, Vaxillaire M, Southam L, Cox RD, Lathrop GM, Boriraj VV, Chen X, Cox NJ, Oda Y, Yano H, Le Beau MM, Yamada S, Nishigori H, Takeda J, Fajans SS, Hattersley AT, Iwasaki N, Hansen T, Pedersen O, Polonsky KS, Turner RC, Velho G, Chèvre J-C, Froguel P, Bell GI: Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3). Nature 384:455-458, 1996
30. Yamagata K, Furuta H, Oda N, Kaisaki PJ, Menzel S, Cox NJ, Fajans SS, Signorini S, Stoffel M, Bell GI: Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1). Nature 384:458-460, 1996
31. Weiner AM, Deininger PL, Efstratiachis A: Nonviral retroposons: genes, pseudogenes, and transposable elements generated by the reverse flow of genetic information. Annu Rev Biochem 55:631-661, 1986
32. German M, Ashcroft S, Docherty K, Edlund H, Edlund T, Goodison S, Imura H, Kennedy G, Madsen O, Melloul D, Moss L, Olson K, Pennutt MA, Philippe J, Robertson BP, Rutter WJ, Serup P, Stein R, Steiner D, Tsai MJ, Walker MD: The insulin gene promoter: a simplified nomenclature. Diabetes 44:1002-1004, 1995
33. Martin ME, Piette J, Yaniv M, Tang W-J, Folk WR: Activation of the polyomavirus enhancer by a murine activator protein (API) homolog and two contiguous proteins. Proc Natl Acad Sci U S A 85:5839-5843, 1988
34. Epstein J, Cai J, Glaser T, Jepeal L, Maas R: Identification of a Pax paired domain recognition sequence and evidence for DNA-dependent conformational changes. J Biol Client 269:8355-8361, 1994
35. Overdier DG, Porcella A, Costa RH: The DNA-binding specificity of the hepatocyte nuclear factor-3/forkhead domain is influenced by amino acid residues adjacent to the recognition helix. Mol Cell Biol 14:2755-2766, 1994